Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract
Human Pathology, 09/01/09
Long KB et al. – SOX2 is preferentially expressed in squamous cell carcinomas of the esophagus and anal canal compared to adenocarcinomas from these sites. SOX2 may be useful in an immunohistochemical panel to differentiate between squamous cell carcinomas and adenocarcinomas of the gastrointestinal tract.
Related Articles
Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma
Genes, Chromosomes and Cancer, 10/02/09
Relevance Score: 80%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
European Journal of Cancer, 12/16/09
Expression of HIF-1alpha and VEGF in colorectal cancer: Association with clinical outcomes and prognostic implications
BMC Cancer, 12/15/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Decreased expression of KLF6 and its significance in gastric carcinoma
Medical Oncology, 12/17/09
A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer
European Journal of Cancer, 12/16/09
A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status
Oncology (Karger), 12/16/09
Sponsor
Article Search
Sponsor
Sponsor